Therapeutic cancer vaccines

This publication has 34 references indexed in Scilit:

• Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
  Current Opinion in Immunology, 2006
• A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma
  International Journal of Cancer, 2005
• Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen
  The Journal of Experimental Medicine, 2005
• Cancer immunotherapy with mRNA‐transfected dendritic cells
  Immunological Reviews, 2004
• Immunotherapy for prostate cancer
  Seminars in Oncology, 2003
• A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation
  European Journal of Immunology, 1999
• The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68
  The Journal of Experimental Medicine, 1997
• Do human cancers express sharedprotectiveantigens? or The necessity of remembrance of things past
  Seminars in Immunology, 1996
• A unique tumor antigen produced by a single amino acid substitution
  Immunity, 1995
• Individually distinct transplantation antigens of chemically induced mouse tumors
  Immunology Today, 1988